Successful Desensitization in a Patient Receiving Pertuzumab and Trastuzumab for ERBB2-Positive Stage IV Breast Cancer: Case Report
Fields of Study & Subjects
Drug-Induced Adverse Reactions
HER2/EGFR in Cancer Research
Pharmacovigilance and Adverse Drug Reactions
Publication details
- Journal / source
- The Canadian Journal of Hospital Pharmacy
- Volume
- 79
- Issue
- 1
- Pages
- e3833–e3833
- Publication date
- 11 February 2026
- Language
- EN